John W. V. Umstead, Chief Financial Officer at G1 Therapeutics, Inc. (GTHX), sold 743 shares at $2.94 ($2K) on 2024-01-04, disclosed to the SEC on 2024-01-08.
Open-market sale of $2k GTHX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.12 | 253 | $789 | 34.3% |
| 2 | $3.12 | 379 | $1K | 51.5% |
| 3 | $2.94 | 111 | $326 | 14.2% |
| Total | $3.09 avg | 743 | $2K | 100% |
| Filing → |
| GTHX | SELL | 2024-03-20 | $20K | — | Filing → |